|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$82,119,756 |
|
|
Indirect Value
|
$12,961,771,173 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,043,890,929 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 40 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-01-25 |
4 |
B |
$6.00 |
$212,814 |
I/I |
35,469 |
1,000,982 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2006-12-22 |
4 |
B |
$3.85 |
$213,266 |
I/I |
55,378 |
543,012 |
1.5 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2011-12-14 |
4 |
B |
$27.29 |
$213,613 |
I/I |
7,828 |
303,264 |
1.5 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-30 |
4 |
S |
$12.03 |
$213,718 |
I/I |
(17,765) |
1,081,432 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-10-29 |
4 |
S |
$12.47 |
$215,815 |
I/I |
(17,311) |
681,500 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-30 |
4 |
B |
$16.44 |
$216,097 |
I/I |
13,142 |
3,171,209 |
2.25 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2004-09-13 |
4 |
B |
$13.56 |
$226,166 |
I/I |
16,680 |
1,232,234 |
2.25 |
- |
|
OCRX |
Ocera Therapeutics Inc |
10% Owner |
|
2012-03-12 |
4 |
B |
$1.87 |
$229,685 |
I/I |
94,306 |
204,336 |
1.5 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-07-24 |
4 |
S |
$15.02 |
$230,933 |
I/I |
(15,374) |
231,125 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2008-12-17 |
4 |
B |
$3.15 |
$231,313 |
I/I |
69,566 |
3,318,136 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-02-07 |
4 |
B |
$9.00 |
$231,681 |
I/I |
25,744 |
7,512,744 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2009-05-21 |
4 |
B |
$6.08 |
$231,912 |
I/I |
38,120 |
7,134,387 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-09 |
4 |
B |
$26.24 |
$233,174 |
I/I |
8,860 |
1,348,282 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2011-08-25 |
4 |
B |
$15.35 |
$234,651 |
I/I |
15,150 |
321,375 |
2.25 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-01-10 |
4 |
B |
$7.47 |
$235,564 |
I/I |
31,538 |
2,381,777 |
1.5 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2006-11-16 |
4 |
B |
$5.80 |
$236,010 |
I/I |
40,671 |
1,611,306 |
1.5 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2006-02-28 |
4 |
S |
$19.90 |
$238,175 |
I/I |
(11,868) |
223,686 |
|
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2009-05-29 |
4 |
S |
$4.12 |
$240,171 |
I/I |
(57,847) |
1,592,174 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-02 |
4 |
S |
$11.88 |
$241,654 |
I/I |
(20,346) |
1,269,093 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2004-09-13 |
4 |
B |
$13.56 |
$242,152 |
I/I |
17,859 |
1,708,989 |
2.25 |
- |
|
INCY |
Incyte Corp |
Director |
|
2008-12-18 |
4 |
B |
$3.56 |
$244,084 |
I/I |
68,463 |
3,386,599 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2008-01-09 |
4 |
B |
$8.95 |
$249,013 |
I/I |
27,828 |
2,182,203 |
1.5 |
- |
|
INCY |
Incyte Corp |
Director |
|
2008-07-31 |
4 |
B |
$9.00 |
$249,516 |
I/I |
27,724 |
159,257 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2006-06-29 |
4 |
B |
$4.08 |
$250,491 |
I/I |
61,443 |
3,710,965 |
2.25 |
- |
|
RDEA |
Ardea Biosciences Inc |
Director |
|
2011-01-20 |
4 |
B |
$26.00 |
$255,190 |
I/I |
9,815 |
93,282 |
2.25 |
- |
|
1397 Records found
|
|
Page 40 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|